Increased micro-RNA 17, 21, and 192 gene expressions improve early diagnosis in non-small cell lung cancer

Medical Oncology

Volumn 31, Issue 9, 2014, Pages 1-5

  Qi, Zhan ^a   Yang, Da Yun ^a   Cao, Jun ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Shanghai Dahua Hospital   (China)

Author keywords

Micro RNAs; NSCLC; Quantitative PCR; Serum

Indexed keywords

MICRORNA; MICRORNA 17; MICRORNA 192; MICRORNA 21; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOUSEKEEPING GENE; HUMAN; MALE; NON SMALL CELL LUNG CANCER; RNA EXTRACTION; RNA TRANSLATION; SMOKING; CARCINOMA, NON-SMALL-CELL LUNG; CASE CONTROL STUDY; GENETICS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION;

CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; HUMANS; LUNG NEOPLASMS; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84906074110     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0195-1     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. National lung screening trial research team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;39(365):395–409.
3. Fu X-A, Li M, Knipp RJ, Nanta MH, Bousamra M. Noninvasive detection of lung cancer using exhaled breath. Cancer Med. 2014;3(1):174–81.
4. Brambilla E, Gazzeri S, Lantuejoul S, Coll JL, Moro D, Negoescu A, et al. P53 mutant immunophenotype and deregulation of P53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer. Clin Cancer Res. 1998;4:1609–18.
5. Niklinski J, Niklinska W, Chyczewski L, Becker HD, Pluygers E. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications. Eur J Cancer Prev. 2001;10:213–26.
6. Shiono S, Omoe K, Endo A. K-ras gene mutation in sputum samples containing atypical cells and adenocarcinoma cells in the lung. Carcinogenesis. 1996;17:1683–6.
7. Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS. K-ras mutations in non-small-cell lung carcinoma: a review. Clin Lung Cancer. 2006;8:30–8.
8. Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer. 2004;4:707–17.
9. Esteeler M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999;59:67–70.
10. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 2002;21:6915–35.
11. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, et al. Isolation of rare circulating tumor cells in cancer patients by microchip technology. Nature. 2007;450:1235–9.
12. Schiller JH. Noninvasive monitoring of tumors. N Engl J Med. 2008;359:418–20.
13. Sk Shenouda. Alahari SK. MicroRNA function in cancer: Oncogene or a tumor suppressor? Cancer Metastasis Rev. 2009;28:369–78.
14. Wang Q, Wang S, Wang H, Li P, Ma Z. MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment. Exp Biol Med. 2012;237:227–35.
15. Mallick R, Patnaik SK, Yendamuri S. MicroRNAs and lung cancer: biology and applications in diagnosis and prognosis. J Carcinog. 2010;9:8.
16. Lawrie CH. microRNA expression in erythropoiesis and erythroid disorders. Br J Haematol. 2010;150:144–51.
17. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–6.
18. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PloS One. 2009;4:e5532.
19. Veronesi G, Bellomi M, Mulshine JL, Pelosi G, Scanagatta P, Paganelli G, et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer. 2008;61:340–9.
20. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall’Olio V, Bernard L, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med. 2011;3:495–503.
21. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other disease. Cell Res. 2008;18:997–1006.
22. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest. 2011;91:579–87.
23. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signature identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010;28:1721–6.
24. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11:441–50.
25. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27:5848–56.
26. Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. Int J Cancer. 2009;126:1283–90.
27. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679–95.
28. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988;80:200–4.
29. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995;268:884–6.
30. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res. 2002;62:6418–23.
31. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996;88:1731–7.
32. Thakue RK, Kumar P, Halder K, Verma A, Kar A, Parent JL, et al. Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res. 2009;37:172–83.
33. Postel EH, Berberich SJ, Rooney JW, Kaetzel DM. Human NM23/nucleoside diphophate kinase regulates gene expression through DNA binding to nuclease-hypersensitivity transcriptional elements. J Bioenerg Biomembr. 2000;32:277–84.